Drug Patents owned by Trevena

1. Drug name - OLINVYK

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8835488 TREVENA Opioid receptor ligands and methods of using and making same
Mar, 2032

(9 years from now)

US9309234 TREVENA Opioid receptor ligands and methods of using and making same
Mar, 2032

(9 years from now)

US11077098 TREVENA Opioid receptor ligands and methods of using and making same
Mar, 2032

(9 years from now)

CN103702561B TREVENA Opioid Receptor Ligands And Methods Of Using And Preparing Method Thereof
Mar, 2032

(9 years from now)

CN103702561A TREVENA Opioid Receptor Ligand, And Use And Preparation Method Thereof
Mar, 2032

(9 years from now)

IN324754B TREVENA An Opioid Receptor Compound
Mar, 2032

(9 years from now)

IN201308346P1 TREVENA Opioid Receptor Ligands And Methods Of Using And Making Same
Mar, 2032

(9 years from now)

EP3290415B1 TREVENA Opioid Receptor Ligands And Methods Of Using And Making Same
Mar, 2032

(9 years from now)

EP2688403B1 TREVENA Opioid Receptor Ligands And Methods Of Using And Making Same
Mar, 2032

(9 years from now)

EP3290415A1 TREVENA Opioid Receptor Ligands And Methods Of Using And Making Same
Mar, 2032

(9 years from now)

EP2688403A1 TREVENA Opioid Receptor Ligands And Methods Of Using And Making Same
Mar, 2032

(9 years from now)

EP2688403A4 TREVENA Opioid Receptor Ligands And Methods Of Using And Making Same
Mar, 2032

(9 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9642842 TREVENA Opioid receptor ligands and methods of using and making same Mar, 2032

(9 years from now)

Drugs and Companies using OLICERIDINE ingredient

Treatment: Management of acute pain by intravenous injection

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
1MG/ML (1MG/ML) SOLUTION;INTRAVENOUS Prescription
2MG/2ML (1MG/ML) SOLUTION;INTRAVENOUS Prescription
30MG/30ML (1MG/ML) SOLUTION;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.